A Review of Approaches to the Metallic and Non-Metallic Synthesis of Benzimidazole (BnZ) and Their Derivatives for Biological Efficacy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Patel, Muhammad | - |
dc.contributor.author | Avashthi, Gopal | - |
dc.contributor.author | Gacem, Amel | - |
dc.contributor.author | Alqahtani, Mohammed S. | - |
dc.contributor.author | Park, Hyun-Kyung | - |
dc.contributor.author | Jeon, Byong-Hun | - |
dc.date.accessioned | 2023-09-26T09:45:28Z | - |
dc.date.available | 2023-09-26T09:45:28Z | - |
dc.date.created | 2023-08-07 | - |
dc.date.issued | 2023-07 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/191273 | - |
dc.description.abstract | Heterocyclic compounds are significant lead drug candidates based on their various structure-activity relationships (SAR), and their use in pharmaceutics is constantly developing. Benzimidazole (BnZ) is synthesized by a condensation reaction between benzene and imidazole. The BnZ structure consists of two nitrogen atoms embedded in a five-membered imide ring which is fused with a benzene ring. This review examines the conventional and green synthesis of metallic and non-metallic BnZ and their derivatives, which have several potential SARs, along with a wide range of pharmacological properties, including anti-cancer, anti-inflammatory, anti-microbial, anti-tubercular, and anti-protozoal properties. These compounds have been proven by pharmacological investigations to be efficient against different strains of microbes. Therefore, in this review, the structural variations of BnZ are listed along with various applications, predominantly related to their biological activities. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.title | A Review of Approaches to the Metallic and Non-Metallic Synthesis of Benzimidazole (BnZ) and Their Derivatives for Biological Efficacy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Hyun-Kyung | - |
dc.contributor.affiliatedAuthor | Jeon, Byong-Hun | - |
dc.identifier.doi | 10.3390/molecules28145490 | - |
dc.identifier.scopusid | 2-s2.0-85165943176 | - |
dc.identifier.wosid | 001039002000001 | - |
dc.identifier.bibliographicCitation | MOLECULES, v.28, no.14, pp.1 - 26 | - |
dc.relation.isPartOf | MOLECULES | - |
dc.citation.title | MOLECULES | - |
dc.citation.volume | 28 | - |
dc.citation.number | 14 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 26 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | ONE-POT SYNTHESIS | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | ANTIPROTOZOAL ACTIVITY | - |
dc.subject.keywordPlus | ANTIMYCOBACTERIAL ACTIVITY | - |
dc.subject.keywordPlus | SUBSTITUTED BENZIMIDAZOLE | - |
dc.subject.keywordPlus | HIGHLY EFFICIENT | - |
dc.subject.keywordPlus | INHIBITORS | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordPlus | ANALOGS | - |
dc.subject.keywordPlus | VITRO | - |
dc.subject.keywordAuthor | benzimidazole | - |
dc.subject.keywordAuthor | biological activity | - |
dc.subject.keywordAuthor | heterocyclic derivatives | - |
dc.identifier.url | https://www.mdpi.com/1420-3049/28/14/5490 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.